As at May 29, 2025, the OSCR stock has a price-to-earnings ratio of 28.75. This is based on the current EPS of $0.48 and the stock price of $13.8 per share. A decrease of 82% has been recorded in the P/E ratio compared to the average of 160.7 of the last 4 quarters.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 122.18 | N/A | $13.44 | $0.11 |
2023 | N/A | N/A | $9.15 | -$1.22 |
2022 | N/A | N/A | $2.46 | -$2.85 |
2021 | N/A | N/A | $7.85 | -$3.2 |
2020 | N/A | N/A | N/A | -$14.16 |
2019 | N/A | N/A | N/A | -$9.06 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 27.31 | -77.65% | $13.11 | $0.48 |
Dec 2024 | 122.18 | -30.87% | $13.44 | $0.11 |
Sep 2024 | 176.75 | -44.14% | $21.21 | $0.12 |
Jun 2024 | 316.4 | N/A | $15.82 | $0.05 |
Mar 2024 | N/A | N/A | $14.87 | -$0.26 |
Dec 2023 | N/A | N/A | $9.15 | -$1.22 |
Sep 2023 | N/A | N/A | $5.57 | -$1.59 |
Jun 2023 | N/A | N/A | $8.06 | -$2.21 |
Mar 2023 | N/A | N/A | $6.54 | -$2.67 |
Dec 2022 | N/A | N/A | $2.46 | -$2.85 |
Sep 2022 | N/A | N/A | $4.99 | -$2.78 |
Jun 2022 | N/A | N/A | $4.25 | -$2.89 |
Mar 2022 | N/A | N/A | $9.97 | -$2.71 |
Dec 2021 | N/A | N/A | $7.85 | -$3.2 |
Sep 2021 | N/A | N/A | $17.39 | -$9.03 |
OSCR's PE ratio is higher than its peer stock PFG.
Stock name | PE ratio | Market cap |
---|---|---|
PFG Principal Financial Group Inc | 16.75 | $17.61B |
OSCR Oscar Health Inc | 28.75 | $3.51B |
LIFW MSP Recovery Inc | N/A | $8.4M |
NEUE NeueHealth Inc. | N/A | $61.16M |
The price to earnings ratio for OSCR stock is 28.75 as of May 29, 2025.
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (May 29, 2025), Oscar Health's stock price is $13.8. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.48. Therefore, Oscar Health's P/E ratio for today is 28.75. PE RATIO(28.75) = STOCK PRICE($13.8) / TTM EPS($0.48)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.